Details of the Drug Combinations

General Information of This Drug (ID: DMVJXOH)

Drug Name
BMS-986012   DMVJXOH
Indication
Disease Entry ICD 11 Status REF
Small-cell lung cancer 2C25.Y Phase 2 [1]
Solid tumour/cancer 2A00-2F9Z Phase 2 [2]
Drug Type
Antibody

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Rosuvastatin + BMS-986012 DC0XSL9 Rosuvastatin Immunosuppression For Disease [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04702880) A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT04702880) A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer. U.S. National Institutes of Health.
3 ClinicalTrials.gov (NCT02101125) Drug Interaction Study With Rosuvastatin